Selection of protective epitopes for Brucella melitensis by DNA vaccination.
about
Cloning, expression and purification of Pwo polymerase from Pyrococcus woeseiLarge scale immune profiling of infected humans and goats reveals differential recognition of Brucella melitensis antigens.A parenteral DNA vaccine protects against pneumonic plagueMurine and bovine γδ T cells enhance innate immunity against Brucella abortus infections.Characterization of periplasmic protein BP26 epitopes of Brucella melitensis reacting with murine monoclonal and sheep antibodies.Immunization of mice with gamma-irradiated Brucella neotomae and its recombinant strains induces protection against virulent B. abortus, B. melitensis, and B. suis challengeSystems biology approach predicts antibody signature associated with Brucella melitensis infection in humans.Serial kinetics of the antibody response against the complete Brucella melitensis ORFeome in focal vertebral brucellosisImproved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting.Antigen-specific acquired immunity in human brucellosis: implications for diagnosis, prognosis, and vaccine development.Progress in Brucella vaccine development.A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plagueAn IL-12 DNA vaccine co-expressing Yersinia pestis antigens protects against pneumonic plagueVaccinology in the genome era.Brucella melitensis T cell epitope recognition in humans with brucellosis in Peru.Immune reactivity of sera obtained from brucellosis patients and vaccinated-rabbits to a fusion protein from Brucella melitensis.In silico analysis of chimeric TF, Omp31 and BP26 fragments of Brucella melitensis for development of a multi subunit vaccine candidate.Development and trial of vaccines against Brucella.Liposomal delivery of p-ialB and p-omp25 DNA vaccines improves immunogenicity but fails to provide full protection against B. melitensis challenge.Immune reactivity of Brucella melitensis-vaccinated rabbit serum with recombinant Omp31 and DnaK proteins.Sustained and differential antibody responses to virulence proteins of Brucella melitensis during acute and chronic infections in human brucellosis.Identification of immunogenic proteins within distinct molecular mass fractions of Flavobacterium psychrophilum.Impact of heat shock protein 60KD in combination with outer membrane proteins on immune response against Brucella melitensis.Alternative strategies for vaccination to brucellosis.Immunogenicity and protective potential of a bacterially expressed recombinant dihydrolipoamide succinyltransferase (rE2o) of Brucella abortus in BALB/c mice.The Microbial Pangenome: Implications for Vaccine Development
P2860
Q24632265-827736A9-1E27-43DA-ACE7-1859DE2ED6CFQ33573403-452A35E5-3656-453B-89C2-B2C5E4DECB0AQ33816162-30C5B42F-B0F1-4657-ACAE-6AB678D672E7Q33963886-ACFDC6EB-F835-42AA-B56D-85DB793D61CFQ34212243-FE886935-F5BF-48F5-93C4-EA48FB197750Q34459329-479538A4-C47E-4BB7-8D61-7E6B3FD3F2CFQ35296643-AC653FD7-ECD6-41F6-AA00-C4D3962C85BCQ35807148-ECC0D2E4-3912-48C6-B6C6-8ACC06F934D9Q35946874-1C24B5ED-2903-4137-B09E-8769AEEA7641Q36159276-300A0992-B3FD-405C-9F3A-92A1804E3E73Q36883753-EE9316DD-B6CB-4C24-BA54-820B4269EF3BQ36898462-4D76A553-55CF-4D2D-A833-5093A4A83541Q37066749-3A33FF2A-C9EF-4B67-A0D4-1FEB6340433EQ37328536-DCA4A93F-A21A-42A2-ACA0-D9623F3BAAA2Q37548090-51D4AE5E-FE97-4D55-BDC0-731F13735210Q39001829-610DB677-B9B9-4AD7-91CB-D767A18EA8A1Q39461733-893E9630-6E87-4B9E-954E-05B05253016CQ40072449-9855BB8B-DDEE-4CAE-8DC1-A0BDF374C800Q41761576-3A7B7C1B-3C54-4D53-80F6-E5CB7FCE25FFQ41931666-4372F968-4E86-46CC-993A-CA599495A7E5Q42283292-E4F022BD-1FDE-4FBC-A244-B80C1DF218F7Q44624977-F4224A3F-6181-436E-ADDD-9C5524474E1AQ46258488-4F847FEF-AF8C-4120-B6F4-F364574EBE8AQ49486807-3CD85FF8-B29B-48C6-B028-7966148CBF17Q54332192-6D4BA1A7-E2C7-4894-AB35-F94D90A38231Q57202981-2686EC92-E47A-46EF-B654-249FAA82E287
P2860
Selection of protective epitopes for Brucella melitensis by DNA vaccination.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Selection of protective epitopes for Brucella melitensis by DNA vaccination.
@ast
Selection of protective epitopes for Brucella melitensis by DNA vaccination.
@en
Selection of protective epitopes for Brucella melitensis by DNA vaccination.
@nl
type
label
Selection of protective epitopes for Brucella melitensis by DNA vaccination.
@ast
Selection of protective epitopes for Brucella melitensis by DNA vaccination.
@en
Selection of protective epitopes for Brucella melitensis by DNA vaccination.
@nl
prefLabel
Selection of protective epitopes for Brucella melitensis by DNA vaccination.
@ast
Selection of protective epitopes for Brucella melitensis by DNA vaccination.
@en
Selection of protective epitopes for Brucella melitensis by DNA vaccination.
@nl
P2093
P2860
P1476
Selection of protective epitopes for Brucella melitensis by DNA vaccination.
@en
P2093
David W Pascual
Mary Hudson
Nancy Walters
Robert F Bargatze
Xinghong Yang
P2860
P304
P356
10.1128/IAI.73.11.7297-7303.2005
P407
P577
2005-11-01T00:00:00Z